Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673954 | SCV000799215 | likely pathogenic | Nemaline myopathy 2 | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000673954 | SCV001400229 | pathogenic | Nemaline myopathy 2 | 2023-04-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 557774). This variant has not been reported in the literature in individuals affected with NEB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg8221Asnfs*31) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). |
Baylor Genetics | RCV003472163 | SCV004200338 | likely pathogenic | Arthrogryposis multiplex congenita 6 | 2023-03-06 | criteria provided, single submitter | clinical testing |